Search

23 Mar 2022: Insights from Tenyks help engineers accelerate their development lifecycle, so they spend less time onboarding new users, reducing customer acquisition costs, and boosting the accuracy of AI. ... Moreover, future new deployments can be onboarded in half

11 Apr 2022: investment. Less than five years later, we again released news about the company. ... This time, however, the news was the completion of a $9.5 million Series A funding round.

9 May 2022: CHO cells transfected to express human FcgRlla allotype 131H as a transmembrane protein with its native intracellular domain.

12 Apr 2022: University of Cambridge spin-out RegGenome announces the completion of a $6 million seed funding round.

9 May 2022: Hybridoma cell line producing YTH 54.12 antibodies raised against human CD45 which are rat monoclonal antibodies of the IgG2b isotype.

14 Jun 2022: Share:. Spirea Limited, a University of Cambridge spin-out company created to advance a new generation of antibody drug conjugate (ADC) therapeutics, has secured funding of £2.4 million. ... We welcome our new investors and thank our existing investors

9 May 2022: CHO cells transfected to express human FcgRllb allotype 131R as a transmembrane protein with its native intracellular domain.

22 Mar 2022: When Cambridge Enterprise was looking to make a film about Consultancy Services, Dr Hugh Hunt, Cambridge University Reader in Engineering Dynamics and...

8 Mar 2022: Even in new construction, it is important to ensure safe environments and understand the short- and long-term environmental impact of a site. ... The proliferation of new sensors and satellite technology has the potential to fuel a revolution in

9 May 2022: Hybridoma cell line producing YFC118.12 antibodies raised against human CD18 which are rat monoclonal antibodies of the IgG2b isotype.

11 Apr 2022: impact of this course is enormous, and we will continue working with the University of Cambridge and the 3C Programme consortium to exploit new mechanisms for collaboration and mutual learning.

9 May 2022: Hybridoma cell line producing YTH 913.12 antibodies raised against human CD28 which are rat monoclonal antibodies of the IgG2b isotype.

8 Mar 2022: Cambridge spin-out DIOSynVax will receive $42 million to develop a vaccine candidate to protect against existing and future variants of SARS-CoV-2.

9 May 2022: Hybridoma cell line producing YTH 89.1 antibodies raised against human CD235a which are rat monoclonal antibodies of the IgG2b isotype.

11 Apr 2022: This limited visibility is an even bigger problem for SMEs. Providing an effective, new way to cut these losses offers a huge commercial opportunity. ... Mining millions of words in news articles, business reports, and social media posts, Versed AI’s

31 May 2022: The round, led by H&M Group via investment arm H&M CO:LAB, includes existing investor, Sagana, as well as new investors Bombyx Growth Fund, PDS Ventures, Regeneration.VC and

9 May 2022: Hybridoma cell line producing YTH 71.3 antibodies raised against human CD66acd which are rat monoclonal antibodies of the IgG2a isotype.

11 Apr 2022: Our consultancy services team supported Department of Chemical Engineering and Biotechnology researchers in testing anti-viral materials.

8 Nov 2022: Carbon Re’s platform, in contrast, is already reducing emissions today, cuts the cost of production, and requires no new equipment. ... The new investment will enable product roll-out into the global cement market and expand into other energy-intensive

9 May 2022: Hybridoma cell line producing YTH 80.103 antibodies raised against human CD45R which are rat monoclonal antibodies of the IgG2b isotype.